Caprin 75 mg gastro-resistant tablets
Authorisation PA0281/268/001 · Pinewood Laboratories Limited
- Licence holder
- Pinewood Laboratories Limited (all products →)
- Active substance
- Acetylsalicylic acid
- Clinical trials
- 13 clinical trials →
- Dosage form
- Gastro-resistant tablet
- Route of administration
- Oral use
- ATC code
- B01AC06
- First authorised
- 31/05/2024
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Acetylsalicylic acid: supply and approvals
21 authorised products on the HPRA list contain Acetylsalicylic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 2 years (since 31 May 2024). The HPRA list marks it as marketed in Ireland.
Other medicines with Acetylsalicylic acid in Ireland
20 other products on the HPRA list contain Acetylsalicylic acid, from 10 licence holders; 12 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Aspirin Krka 75 mg gastro-resistant tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Disprin Direct 300 mg Orodispersible Tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Disprin Extra Strength 500 mg Effervescent tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Disprin Original 300 mg Dispersible Tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Excedrin 250 mg/ 250 mg/ 65 mg film coated tablets | Haleon Ireland Limited | National authorisation (PA) | Marketed |
| Nu-seals 75 mg gastro-resistant tablets | Alliance Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/10 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/2.5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/40 mg/10 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/40 mg/2.5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/40 mg/5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
The licence holder
Pinewood Laboratories Limited holds 91 products on the HPRA list, with 45 different active substances; 62 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.